Funder
Tehran university of medical sciences
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Maqbool M, Gani I. Utilization of Statins in Reducing Comorbidities of Diabetes Mellitus: A Systematic Review. Journal of Pharmacy Practice and Community Medicine. 2018;4(4):193–6.
2. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
3. Shora HA. Pattern of Statin use in patients with diabetes mellitus type 2 for primary and secondary prevention of cardiovascular disease in Saudi Arabia. African J Diabetes Med. 2020;28(2):1–8.
4. Moradi Y, Baradaran HR, Djalalinia S, Chinekesh A, Khamseh ME, Dastoorpoor M, et al. Complications of type 2 diabetes in Iranian population: An updated systematic review and meta-analysis. Diabetes Metab Syndr. 2019;13(3):2300–12.
5. Ampofo AG, Boateng EB. Beyond 2020: Modelling obesity and diabetes prevalence. Diab Res Clin Pract. 2020;167:108362.